Independence Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$294K Hold
8,563
0.32% 51
2017
Q3
$290K Buy
8,563
+606
+8% +$19.5K 0.33% 54
2017
Q2
$254K Buy
+7,957
New +$251K 0.3% 64
2017
Q1
Sell
-10,324
Closed -$318K 80
2016
Q4
$318K Sell
10,324
-4,932
-32% -$151K 0.44% 50
2016
Q3
$490K Buy
15,256
+303
+2% +$10.1K 0.8% 24
2016
Q2
$499K Hold
14,953
0.77% 29
2016
Q1
$420K Sell
14,953
-15,659
-51% -$447K 0.66% 30
2015
Q4
$937K Sell
30,612
-2,172
-7% -$68.3K 1.22% 23
2015
Q3
$977K Sell
32,784
-6,803
-17% -$218K 1% 24
2015
Q2
$1.26M Buy
39,587
+10,830
+38% +$353K 0.85% 27
2015
Q1
$949K Hold
28,757
0.6% 34
2014
Q4
$850K Buy
28,757
+13,871
+93% +$398K 0.51% 40
2014
Q3
$417K Buy
14,886
+5,642
+61% +$158K 0.28% 62
2014
Q2
$260K Buy
+9,244
New +$264K 0.17% 87

Other funds holding PFE

Independence Trust's PFE Position: Q4 2017 in Review

Independence Trust held its Pfizer (PFE) position steady in Q4 2017 at 8,563 shares worth $294K. The position accounts for 0.32% of the portfolio, ranked #51.

Independence Trust first reported a position in PFE in Q2 2014 and has held it in 14 quarters since. The position peaked at $1.26M in Q2 2015. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Independence Trust held 8,563 shares of Pfizer worth $294K as of Q4 2017.
  • Independence Trust left its Pfizer share count unchanged in Q4 2017.
  • Pfizer made up 0.32% of Independence Trust's portfolio in Q4 2017, its #51 holding.
  • Independence Trust first reported a position in Pfizer in Q2 2014 and has held it in 14 quarters since.
  • Independence Trust's Pfizer position peaked at $1.26M in Q2 2015.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Independence Trust's 13F filing for Q4 2017, filed 8 Feb 2018.